India News | Reported by Uma Sudhir, Edited by Arun Nair | Saturday July 3, 2021
Bharat Biotech's Covaxin is overall 77.8 per cent effective "against symptomatic COVID-19", the vaccine maker said today in a statement, citing the data from the third phase of clinical trials. The data, however, is yet to be peer-reviewed.
www.ndtv.com